LCM
EXAS

Legato Capital Management’s Exact Sciences EXAS Stock Holding History

Legato Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,650
Closed -$3.32M – 784
2025
Q4 		$3.32M Buy
+32,650
New +$2.62M 0.29% 73
2018
Q1 		– Sell
-7,171
Closed -$377K – 153
2017
Q4 		$377K Hold
7,171
– – 0.05% 228
2017
Q3 		$338K Hold
7,171
– – 0.05% 241
2017
Q2 		$254K Buy
+7,171
New +$221K 0.11% 184

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Legato Capital Management's EXAS Position: Q1 2026 in Review

Legato Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 32,650 shares — an estimated $3.32M sold.

Legato Capital Management first reported a position in EXAS in Q2 2017 and held it in 4 quarters. The position peaked at $3.32M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Legato Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Legato Capital Management sold 32,650 Exact Sciences shares in Q1 2026, an estimated $3.32M.
  • Legato Capital Management first reported a position in Exact Sciences in Q2 2017 and held it in 4 quarters.
  • Legato Capital Management's Exact Sciences position peaked at $3.32M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.